Summary

Market Summary:
As per Market Research Future analysis, the Japan non-invasive prenatal testing market size was estimated at 68.25 USD Million in 2024. The Japan non invasive-prenatal-testing market is projected to grow from 75.47 USD Million in 2025 to 206.25 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 10.5% during the forecast period 2025 - 2035

Market Drivers:
The non invasive-prenatal-testing market is experiencing growth due to the rising birth rates in Japan. Recent statistics indicate that the birth rate has shown a slight increase, which may lead to a higher demand for prenatal testing services. As more expectant mothers seek to ensure the health of their unborn children, the market for non invasive prenatal testing is likely to expand. This trend is further supported by the increasing number of women choosing to have children later in life, which often necessitates more comprehensive prenatal care. The combination of these factors suggests a robust future for the non invasive-prenatal-testing market in Japan. Government initiatives aimed at improving maternal and child health are positively impacting the non invasive-prenatal-testing market. In Japan, the government has implemented various programs to promote prenatal care, which includes funding for advanced testing methods. These initiatives not only raise awareness about the importance of prenatal testing but also provide financial support for healthcare facilities to adopt new technologies.

Market Segment Analysis:
In the Japan non invasive-prenatal-testing market, Cell-Free Fetal DNA Testing holds the largest market share among the various testing types, significantly leading over Biochemical Markers Testing and Ultrasound Screening. This dominance is attributed to the high accuracy and reliability of DNA tests, which has led to increased adoption rates among healthcare providers and expectant parents. On the other hand, while Biochemical Markers Testing and Ultrasound Screening also contribute to the market, they fall behind in terms of prevalence and popularity. Growth trends within the segment indicate a robust increase in demand for Cell-Free Fetal DNA Testing, driven by technological advancements and a heightened focus on maternal-fetal health. Moreover, Biochemical Markers Testing is emerging rapidly due to its affordability and ease of access, making it an appealing option for prenatal care.

Regional Analysis:
The non invasive-prenatal-testing market is experiencing notable growth, driven by advancements in technology and increasing awareness among expectant parents. In Japan, the demand for these tests is rising as they offer a safer alternative to invasive procedures, reducing risks associated with prenatal diagnostics. The integration of cutting-edge genetic analysis techniques is enhancing the accuracy of these tests, which is likely to further boost their adoption. Additionally, healthcare providers are increasingly recommending non invasive options, contributing to a shift in prenatal care practices. Moreover, the regulatory environment in Japan appears to be evolving to support the expansion of the non invasive-prenatal-testing market.

Major Players:
The following companies are key participants in the Japan Non Invasive Prenatal Testing Market, playing a crucial role in market development through technological innovation, strategic partnerships, and competitive product offerings.

ページTOPに戻る

Table of Contents

TABLE OF CONTENT

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
EXECUTIVE SUMMARY
Market Overview
Key Findings
Market Segmentation
Competitive Landscape
Challenges and Opportunities
Future Outlook

2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
MARKET INTRODUCTION
Definition
Scope of the study
Research Objective
Assumption
Limitations
RESEARCH METHODOLOGY
Overview
Data Mining
Secondary Research
Primary Research
Primary Interviews and Information Gathering Process
Breakdown of Primary Respondents
Forecasting Model
Market Size Estimation
Bottom-Up Approach
Top-Down Approach
Data Triangulation
Validation

3 SECTION III: QUALITATIVE ANALYSIS
MARKET DYNAMICS
Overview
Drivers
Restraints
Opportunities
MARKET FACTOR ANALYSIS
Value chain Analysis
Porter's Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of New Entrants
Threat of Substitutes
Intensity of Rivalry
COVID-19 Impact Analysis
Market Impact Analysis
Regional Impact
Opportunity and Threat Analysis

4 SECTION IV: QUANTITATIVE ANALYSIS
Non-Invasive Prenatal Testing (NIPT) Market Segmentation
Non-Invasive Prenatal Testing (NIPT) Market By Test Type (USD Billion, 2019-2035)
Cell-Free Fetal DNA Testing
Biochemical Markers Testing
Ultrasound Screening
Non-Invasive Prenatal Testing (NIPT) Market By Application (USD Billion, 2019-2035)
Trisomy Detection
Single Gene Disorders
Sex Chromosome Abnormalities
Non-Invasive Prenatal Testing (NIPT) Market By Technology (USD Billion, 2019-2035)
Next-Generation Sequencing
Microarray Analysis
Massively Parallel Sequencing
Non-Invasive Prenatal Testing (NIPT) Market By End User (USD Billion, 2019-2035)
Hospitals
Diagnostic Laboratories
Research Institutions
Non-Invasive Prenatal Testing (NIPT) Market By Regional (USD Billion, 2019-2035)
North America
Europe
South America
Asia Pacific
Middle East and Africa
Non-Invasive Prenatal Testing (NIPT) Market SECTION V: COMPETITIVE ANALYSIS
Competitive Landscape
Overview
Competitive Analysis
Market share Analysis
Major Growth Strategy in the non-invasive prenatal testing market
Competitive Benchmarking
Leading Players in Terms of Number of Developments in the non-invasive prenatal testing market
Key developments and growth strategies
New Product Launch/Service Deployment
Merger & Acquisitions
Joint Ventures
Major Players Financial Matrix
Sales and Operating Income
Major Players R&D Expenditure. 2023
Company Profiles
Nippon Gene
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Fujirebio
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Mitsubishi Chemical
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Sysmex Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Takara Bio
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Chugai Pharmaceutical
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Astellas Pharma
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Hiroshima University
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Appendix
References
Related Reports

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES
LIST OF ASSUMPTIONS
Japan NON-INVASIVE PRENATAL TESTING MARKET SIZE ESTIMATES; FORECAST
TABLE 1 BY TYPE, 2026-2035 (USD Million)
TABLE 2 BY TYPE, 2026-2035 (USD Million)
TABLE 3 BY APPLICATION, 2026-2035 (USD Million)
TABLE 4 BY APPLICATION, 2026-2035 (USD Million)
TABLE 5 BY TECHNOLOGY, 2026-2035 (USD Million)
TABLE 6 BY TECHNOLOGY, 2026-2035 (USD Million)
TABLE 7 BY END USER, 2026-2035 (USD Million)
TABLE 8 BY END USER, 2026-2035 (USD Million)
PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
ACQUISITION/PARTNERSHIP

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 JAPAN NON-INVASIVE PRENATAL TESTING MARKET ANALYSIS BY TYPE
FIGURE 3 JAPAN NON-INVASIVE PRENATAL TESTING MARKET ANALYSIS BY APPLICATION
FIGURE 4 JAPAN NON-INVASIVE PRENATAL TESTING MARKET ANALYSIS BY TECHNOLOGY
FIGURE 5 JAPAN NON-INVASIVE PRENATAL TESTING MARKET ANALYSIS BY END USER
FIGURE 6 KEY BUYING CRITERIA OF NON-INVASIVE PRENATAL TESTING MARKET
FIGURE 7 RESEARCH PROCESS OF MRFR
FIGURE 8 DRO ANALYSIS OF JAPAN NON-INVASIVE PRENATAL TESTING MARKET
FIGURE 9 DRIVERS IMPACT ANALYSIS: JAPAN NON-INVASIVE PRENATAL TESTING MARKET
FIGURE 10 RESTRAINTS IMPACT ANALYSIS: JAPAN NON-INVASIVE PRENATAL TESTING MARKET
FIGURE 11 SUPPLY / VALUE CHAIN: JAPAN NON-INVASIVE PRENATAL TESTING MARKET
FIGURE 12 JAPAN NON-INVASIVE PRENATAL TESTING MARKET, BY TYPE, 2024 (% SHARE)
FIGURE 13 JAPAN NON-INVASIVE PRENATAL TESTING MARKET, BY TYPE, 2024 TO 2035 (USD Million)
FIGURE 14 JAPAN NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 15 JAPAN NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2024 TO 2035 (USD Million)
FIGURE 16 JAPAN NON-INVASIVE PRENATAL TESTING MARKET, BY TECHNOLOGY, 2024 (% SHARE)
FIGURE 17 JAPAN NON-INVASIVE PRENATAL TESTING MARKET, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
FIGURE 18 JAPAN NON-INVASIVE PRENATAL TESTING MARKET, BY END USER, 2024 (% SHARE)
FIGURE 19 JAPAN NON-INVASIVE PRENATAL TESTING MARKET, BY END USER, 2024 TO 2035 (USD Million)
FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS